Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Top Cited Papers
- 20 July 2004
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 10 (1), 40-68
- https://doi.org/10.1038/sj.mp.4001558
Abstract
This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a ‘genetic cytoarchitecture’ would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.Keywords
This publication has 376 references indexed in Scilit:
- Regional expression of RGS4 mRNA in human brain†European Journal of Neuroscience, 2004
- Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stressMolecular Psychiatry, 2004
- Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorderMolecular Psychiatry, 2004
- Association between PRODH and schizophrenia is not confirmedMolecular Psychiatry, 2003
- Back signaling by the Nrg-1 intracellular domainThe Journal of cell biology, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variationHuman Genetics, 2002
- The α7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophreniaJournal of Chemical Neuroanatomy, 2000
- Cortical regulation of subcortical dopamine systems and its possible relevance to schizophreniaJournal of Neural Transmission, 1993
- Prenatal developmental disturbances in the limbic allocortex in schizophrenicsJournal of Neural Transmission, 1986